4-Hydroxybutyric Acid
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Gamma Hydroxybutyric Acid.
Acepromazine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Acepromazine.
Aceprometazine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Aceprometazine.
Advertisement
Albuterol
Salbutamol may increase the QTc-prolonging activities of Droperidol.
Alfaxalone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Alfaxalone.
Alfentanil
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Alfentanil.
Advertisement
Alfuzosin
Alfuzosin may increase the QTc-prolonging activities of Droperidol.
Almotriptan
The risk or severity of adverse effects can be increased when Almotriptan is combined with Droperidol.
Alphaprodine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Alphaprodine.
Advertisement
Alprazolam
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Alprazolam.
Amantadine
The therapeutic efficacy of Droperidol can be decreased when used in combination with Amantadine.
Amiodarone
Droperidol may increase the QTc-prolonging activities of Amiodarone.
Amisulpride
Droperidol may increase the antipsychotic activities of Amisulpride.
Amitriptyline
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.
Amobarbital
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Amobarbital.
Amoxapine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Amphetamine
Droperidol may decrease the stimulatory activities of Amphetamine.
Anagrelide
Droperidol may increase the QTc-prolonging activities of Anagrelide.
Apomorphine
The therapeutic efficacy of Droperidol can be decreased when used in combination with Apomorphine.
Arformoterol
Arformoterol may increase the QTc-prolonging activities of Droperidol.
Aripiprazole
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.
Arsenic Trioxide
Droperidol may increase the QTc-prolonging activities of Arsenic trioxide.
Artemether
Droperidol may increase the QTc-prolonging activities of Artemether.
Articaine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Articaine.
Asenapine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Asenapine.
Atazanavir
Atazanavir may increase the QTc-prolonging activities of Droperidol.
Atomoxetine
Atomoxetine may increase the QTc-prolonging activities of Droperidol.
Azelastine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Azithromycin
Azithromycin may increase the QTc-prolonging activities of Droperidol.
Baclofen
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Baclofen.
Barbital
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Barbital.
Bedaquiline
Droperidol may increase the QTc-prolonging activities of Bedaquiline.
Benoxinate
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.
Benperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Benperidol.
Benzocaine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Benzocaine.
Benzphetamine
Droperidol may decrease the stimulatory activities of Benzphetamine.
Benzyl Alcohol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Benzyl alcohol.
Bortezomib
Bortezomib may increase the QTc-prolonging activities of Droperidol.
Brexpiprazole
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Brexpiprazole.
Brimonidine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Brimonidine.
Bromazepam
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Bromazepam.
Bromocriptine
The therapeutic efficacy of Droperidol can be decreased when used in combination with Bromocriptine.
Bromperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Bromperidol.
Brompheniramine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Brompheniramine.
Brotizolam
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Brotizolam.
Bupivacaine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Bupivacaine.
Buprenorphine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buserelin
Buserelin may increase the QTc-prolonging activities of Droperidol.
Buspirone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Buspirone.
Butabarbital
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Butabarbital.
Butalbital
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Butalbital.
Butamben
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Butamben.
Butobarbital
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Butethal.
Butorphanol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Butorphanol.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Droperidol.
Carbamazepine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.
Carbinoxamine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Carbinoxamine.
Carisoprodol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Carisoprodol.
Ceritinib
Droperidol may increase the QTc-prolonging activities of Ceritinib.
Cetirizine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cetirizine.
Chloral Hydrate
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chloral hydrate.
Chlordiazepoxide
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chlordiazepoxide.
Chlormethiazole
Droperidol may increase the central nervous system depressant (CNS depressant) activities of clomethiazole.
Chlormezanone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chlormezanone.
Chloroprocaine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chloroprocaine.
Chloroquine
Droperidol may increase the QTc-prolonging activities of Chloroquine.
Chlorpheniramine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chlorphenamine.
Chlorpromazine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chlorpromazine.
Chlorprothixene
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.
Chlorzoxazone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Chlorzoxazone.
Ciprofloxacin
Droperidol may increase the QTc-prolonging activities of Ciprofloxacin.
Cisapride
Droperidol may increase the QTc-prolonging activities of Cisapride.
Citalopram
Droperidol may increase the QTc-prolonging activities of Citalopram.
Clarithromycin
Droperidol may increase the QTc-prolonging activities of Clarithromycin.
Clemastine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Clemastine.
Clidinium
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Clidinium.
Clidinium bromide
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Clidinium.
Clobazam
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Clobazam.
Clomipramine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Clomipramine.
Clonazepam
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Clonazepam.
Clonidine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Clonidine.
Clorazepate
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Clorazepate.
CLORAZEPIC ACID
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Clorazepate.
Clozapine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Clozapine.
Cocaine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cocaine.
Codeine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Codeine.
Codeine Anhydrous
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Codeine.
CODEINE POLISTIREX
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Codeine.
Crizotinib
Droperidol may increase the QTc-prolonging activities of Crizotinib.
Cyclizine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cyclizine.
Cyclobenzaprine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cyclobenzaprine.
Cyproheptadine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.
Dabrafenib
Dabrafenib may increase the QTc-prolonging activities of Droperidol.
Dantrolene
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dantrolene.
Dapiprazole
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dapiprazole.
Dasatinib
Dasatinib may increase the QTc-prolonging activities of Droperidol.
Dasatinib Anhydrous
Dasatinib may increase the QTc-prolonging activities of Droperidol.
Degarelix
Degarelix may increase the QTc-prolonging activities of Droperidol.
Desflurane
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Desflurane.
Desipramine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Desipramine.
Desloratadine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Desloratadine.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Droperidol is combined with Desvenlafaxine.
Deutetrabenazine
Droperidol may increase the QTc-prolonging activities of Deutetrabenazine.
Dexbrompheniramine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dexbrompheniramine.
Dexmedetomidine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dexmedetomidine.
Dextroamphetamine
Droperidol may decrease the stimulatory activities of Dextroamphetamine.
Dextromethorphan
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Droperidol.
Dextromoramide
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dextromoramide.
Dezocine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dezocine.
Diazepam
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Diazepam.
Dibucaine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Cinchocaine.
Diethylpropion
Droperidol may decrease the stimulatory activities of Diethylpropion.
Difenoxin
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Difenoxin.
Dihydrocodeine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dihydrocodeine.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Droperidol.
Dimenhydrinate
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dimenhydrinate.
Diphenhydramine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Diphenhydramine.
Diphenoxylate
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Diphenoxylate.
Disopyramide
Droperidol may increase the QTc-prolonging activities of Disopyramide.
Dofetilide
Droperidol may increase the QTc-prolonging activities of Dofetilide.
Dolasetron
Droperidol may increase the QTc-prolonging activities of Dolasetron.
Domperidone
Droperidol may increase the QTc-prolonging activities of Domperidone.
Doxepin
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Doxepin.
Doxylamine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Doxylamine.
Dronedarone
Droperidol may increase the QTc-prolonging activities of Dronedarone.
Duloxetine
The risk or severity of adverse effects can be increased when Droperidol is combined with Duloxetine.
Dyclonine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dyclonine.
Efavirenz
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Efavirenz.
Eletriptan
The risk or severity of adverse effects can be increased when Eletriptan is combined with Droperidol.
Eliglustat
Droperidol may increase the QTc-prolonging activities of Eliglustat.
Enflurane
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Enflurane.
Entacapone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Entacapone.
ergoloid mesylates, USP
The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Droperidol.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Droperidol.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Droperidol.
Eribulin
Eribulin may increase the QTc-prolonging activities of Droperidol.
Erythromycin
Erythromycin may increase the QTc-prolonging activities of Droperidol.
Escitalopram
Droperidol may increase the QTc-prolonging activities of Escitalopram.
Estazolam
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Estazolam.
Eszopiclone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Eszopiclone.
Ethanol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ethchlorvynol.
Ethosuximide
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ethosuximide.
Ethotoin
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ethotoin.
Ethyl Chloride
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ethyl chloride.
Ethyl Loflazepate
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ethyl loflazepate.
Ethylmorphine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ethylmorphine.
Etidocaine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Etidocaine.
Etifoxine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Etifoxine.
Etomidate
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Etomidate.
Ezogabine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ezogabine.
Famotidine
Famotidine may increase the QTc-prolonging activities of Droperidol.
Felbamate
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Felbamate.
Fentanyl
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fentanyl.
Fexofenadine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fexofenadine.
Fingolimod
Fingolimod may increase the QTc-prolonging activities of Droperidol.
Flecainide
Droperidol may increase the QTc-prolonging activities of Flecainide.
Flibanserin
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Flibanserin.
Fluconazole
Fluconazole may increase the QTc-prolonging activities of Droperidol.
Flunarizine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Flunarizine.
Flunitrazepam
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Flunitrazepam.
Fluoxetine
Droperidol may increase the QTc-prolonging activities of Fluoxetine.
Flupenthixol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Flupentixol.
Fluphenazine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.
Flurazepam
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Flurazepam.
Fluspirilene
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fluspirilene.
Fluticasone propionate
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fluticasone propionate.
Fluvoxamine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fluvoxamine.
Formoterol
Formoterol may increase the QTc-prolonging activities of Droperidol.
Foscarnet
Foscarnet may increase the QTc-prolonging activities of Droperidol.
Fosphenytoin
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fosphenytoin.
Fospropofol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fospropofol.
Frovatriptan
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Droperidol.
Gabapentin
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Gabapentin.
Gabapentin Enacarbil
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Gabapentin Enacarbil.
Gadobenate
Droperidol may increase the QTc-prolonging activities of Gadobenic acid.
Galantamine
Galantamine may increase the QTc-prolonging activities of Droperidol.
Gemifloxacin
Droperidol may increase the QTc-prolonging activities of Gemifloxacin.
Gemifloxacin Mesylate
Droperidol may increase the QTc-prolonging activities of Gemifloxacin.
Glutethimide
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Glutethimide.
Goserelin
Goserelin may increase the QTc-prolonging activities of Droperidol.
Granisetron
Droperidol may increase the QTc-prolonging activities of Granisetron.
Guanfacine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Guanfacine.
Halazepam
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Halazepam.
Haloperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Haloperidol.
Halothane
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Halothane.
Heroin
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Heroin.
Hexobarbital
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Hexobarbital.
Histrelin
Histrelin may increase the QTc-prolonging activities of Droperidol.
Hydrocodone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.
Hydroxyzine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Hydroxyzine.
Ibandronate
Ibandronate may increase the QTc-prolonging activities of Droperidol.
Ibandronic Acid
Ibandronate may increase the QTc-prolonging activities of Droperidol.
Ibutilide
Droperidol may increase the QTc-prolonging activities of Ibutilide.
Iloperidone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Iloperidone.
Imipramine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Imipramine.
Indacaterol
Indacaterol may increase the QTc-prolonging activities of Droperidol.
Indapamide
Indapamide may increase the QTc-prolonging activities of Droperidol.
Isocarboxazid
The therapeutic efficacy of Droperidol can be increased when used in combination with Isocarboxazid.
Isoflurane
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Isoflurane.
Isradipine
Isradipine may increase the QTc-prolonging activities of Droperidol.
Itraconazole
Itraconazole may increase the QTc-prolonging activities of Droperidol.
Ivabradine
Ivabradine may increase the QTc-prolonging activities of Droperidol.
Ketamine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ketamine.
Ketazolam
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ketazolam.
Ketoconazole
Ketoconazole may increase the QTc-prolonging activities of Droperidol.
Lamotrigine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Lamotrigine.
Lapatinib
Lapatinib may increase the QTc-prolonging activities of Droperidol.
Lenvatinib
Droperidol may increase the QTc-prolonging activities of Lenvatinib.
Lenvatinib Mesylate
Droperidol may increase the QTc-prolonging activities of Lenvatinib.
Leuprolide
Leuprolide may increase the QTc-prolonging activities of Droperidol.
Levetiracetam
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Levetiracetam.
Levobupivacaine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Levobupivacaine.
Levocabastine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Levocabastine.
Levocetirizine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Levocetirizine.
Levodopa
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Levodopa.
Levofloxacin
Droperidol may increase the QTc-prolonging activities of Levofloxacin.
Levofloxacin Anhydrous
Droperidol may increase the QTc-prolonging activities of Levofloxacin.
Levomethadyl
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Droperidol is combined with Levomilnacipran.
Levorphanol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Levorphanol.
Lidocaine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Lidocaine.
Linezolid
The risk or severity of adverse effects can be increased when Linezolid is combined with Droperidol.
Lisdexamfetamine
Droperidol may decrease the stimulatory activities of Lisdexamfetamine.
Lisdexamfetamine Dimesylate
Droperidol may decrease the stimulatory activities of Lisdexamfetamine.
Lithium
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Lithium.
Lithium Cation
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Lithium.
Lopinavir
Droperidol may increase the QTc-prolonging activities of Lopinavir.
Loratadine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Loratadine.
Lorazepam
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Lorazepam.
Lorcaserin
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Droperidol.
Lormetazepam
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Lormetazepam.
Loxapine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Loxapine.
Lumefantrine
Droperidol may increase the QTc-prolonging activities of Lumefantrine.
Lurasidone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Lurasidone.
Macimorelin
Droperidol may increase the QTc-prolonging activities of Macimorelin.
Magnesium Sulfate
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Magnesium sulfate.
Maprotiline
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Maprotiline.
Meclizine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Meclizine.
Mefloquine
Mefloquine may increase the QTc-prolonging activities of Droperidol.
Melatonin
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Melatonin.
Meperidine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pethidine.
Mephentermine
Droperidol may decrease the stimulatory activities of Mephentermine.
Mephobarbital
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methylphenobarbital.
Mepivacaine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Mepivacaine.
Meprobamate
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Meprobamate.
Mequitazine
Droperidol may increase the arrhythmogenic activities of Mequitazine.
Mesoridazine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Mesoridazine.
Metaxalone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Metaxalone.
Methadone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methadone.
Methadyl Acetate
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methadyl Acetate.
Methamphetamine
Droperidol may decrease the stimulatory activities of Methamphetamine.
Methapyrilene
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methapyrilene.
Methaqualone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methaqualone.
Methocarbamol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methocarbamol.
Methohexital
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methohexital.
Methotrimeprazine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methoxyflurane.
Methsuximide
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methsuximide.
Methylphenidate
The risk or severity of adverse effects can be increased when Droperidol is combined with Methylphenidate.
Metoclopramide
The risk or severity of adverse effects can be increased when Droperidol is combined with Metoclopramide.
Metronidazole
Metronidazole may increase the QTc-prolonging activities of Droperidol.
Metylperon
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Melperone.
Metyrosine
The risk or severity of adverse effects can be increased when Metyrosine is combined with Droperidol.
Midazolam
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Midazolam.
Mifepristone
Droperidol may increase the QTc-prolonging activities of Mifepristone.
Milnacipran
The risk or severity of adverse effects can be increased when Droperidol is combined with Milnacipran.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Droperidol.
Mirabegron
Mirabegron may increase the QTc-prolonging activities of Droperidol.
Mirtazapine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Moclobemide
The risk or severity of adverse effects can be increased when Moclobemide is combined with Droperidol.
Moexipril
Moexipril may increase the QTc-prolonging activities of Droperidol.
Molindone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Molindone.
Morphine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Morphine.
Moxifloxacin
Moxifloxacin may increase the QTc-prolonging activities of Droperidol.
Nabilone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Nabilone.
Nalbuphine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Nalbuphine.
Naratriptan
The risk or severity of adverse effects can be increased when Naratriptan is combined with Droperidol.
Nefazodone
The risk or severity of adverse effects can be increased when Droperidol is combined with Nefazodone.
Nelfinavir
Nelfinavir may increase the QTc-prolonging activities of Droperidol.
Nicardipine
Nicardipine may increase the QTc-prolonging activities of Droperidol.
Nilotinib
Droperidol may increase the QTc-prolonging activities of Nilotinib.
Nitrazepam
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Nitrazepam.
Nitrous Oxide
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Nitrous oxide.
Norfloxacin
Norfloxacin may increase the QTc-prolonging activities of Droperidol.
Norflurane
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Norflurane.
Normethadone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Normethadone.
Nortriptyline
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.
Octreotide
Octreotide may increase the QTc-prolonging activities of Droperidol.
Ofloxacin
Droperidol may increase the QTc-prolonging activities of Ofloxacin.
Olanzapine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Olanzapine.
Olodaterol
Olodaterol may increase the QTc-prolonging activities of Droperidol.
Olopatadine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Olopatadine.
Ondansetron
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ondansetron.
Opium
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Opium.
Orphenadrine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Oxazepam
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxazepam.
Oxprenolol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxprenolol.
Oxycodone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxycodone.
Oxymorphone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxymorphone.
Oxytocin
Oxytocin may increase the QTc-prolonging activities of Droperidol.
p-Hydroxyamphetamine
Droperidol may decrease the stimulatory activities of Hydroxyamphetamine.
Paliperidone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Paliperidone.
Panobinostat
Droperidol may increase the QTc-prolonging activities of Panobinostat.
Paraldehyde
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Morphine.
Paroxetine
The risk or severity of adverse effects can be increased when Droperidol is combined with Paroxetine.
Pasireotide
Pasireotide may increase the QTc-prolonging activities of Droperidol.
Pazopanib
Droperidol may increase the QTc-prolonging activities of Pazopanib.
Pentamidine
Droperidol may increase the QTc-prolonging activities of Pentamidine.
Pentazocine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pentazocine.
Pentobarbital
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pentobarbital.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Droperidol.
Perazine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Perazine.
Perflutren
Droperidol may increase the QTc-prolonging activities of Perflutren.
Perphenazine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Perphenazine.
Phenelzine
The risk or severity of adverse effects can be increased when Phenelzine is combined with Droperidol.
Phenobarbital
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Phenobarbital.
Phenoxyethanol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Phenoxyethanol.
Phentermine
Droperidol may decrease the stimulatory activities of Phentermine.
PHENTERMINE RESIN
Droperidol may decrease the stimulatory activities of Phentermine.
Phenytoin
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Phenytoin.
Pimozide
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pimozide.
Pipamperone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pipamperone.
Pipothiazine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pipotiazine.
Piribedil
The therapeutic efficacy of Droperidol can be decreased when used in combination with Piribedil.
Pirinitramide
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Piritramide.
Pizotyline
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pizotifen.
Pomalidomide
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pomalidomide.
Posaconazole
Posaconazole may increase the QTc-prolonging activities of Droperidol.
Pramipexole
Droperidol may increase the sedative activities of Pramipexole.
Pramoxine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pramocaine.
Prazepam
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Prazepam.
Pregabalin
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Pregabalin.
Prilocaine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Prilocaine.
Primaquine
Droperidol may increase the QTc-prolonging activities of Primaquine.
Primidone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Primidone.
Procainamide
Droperidol may increase the QTc-prolonging activities of Procainamide.
Procaine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Procaine.
Procarbazine
The risk or severity of adverse effects can be increased when Procarbazine is combined with Droperidol.
Prochlorperazine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Prochlorperazine.
Promazine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Promazine.
Promethazine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Promethazine.
Propafenone
Droperidol may increase the QTc-prolonging activities of Propafenone.
Proparacaine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Proparacaine.
Propofol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Propofol.
Propoxyphene
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dextropropoxyphene.
Protriptyline
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Protriptyline.
Pseudoephedrine
Droperidol may decrease the stimulatory activities of Pseudoephedrine.
Quazepam
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Quazepam.
Quetiapine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Quetiapine fumarate
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.
Quinagolide
The therapeutic efficacy of Quinagolide can be decreased when used in combination with Droperidol.
Quinidine
Droperidol may increase the QTc-prolonging activities of Quinidine.
Quinine
Droperidol may increase the QTc-prolonging activities of Quinine.
Ramelteon
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ramelteon.
Ranolazine
Ranolazine may increase the QTc-prolonging activities of Droperidol.
Rasagiline
The risk or severity of adverse effects can be increased when Rasagiline is combined with Droperidol.
Remifentanil
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Remifentanil.
Remoxipride
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Remoxipride.
Reserpine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Reserpine.
Ribociclib
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Droperidol.
Rilpivirine
Rilpivirine may increase the QTc-prolonging activities of Droperidol.
Risperidone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Risperidone.
Ritonavir
Ritonavir may increase the QTc-prolonging activities of Droperidol.
Rizatriptan
The risk or severity of adverse effects can be increased when Rizatriptan is combined with Droperidol.
Ropinirole
Droperidol may increase the sedative activities of Ropinirole.
Ropivacaine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ropivacaine.
Rotigotine
Droperidol may increase the sedative activities of Rotigotine.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Droperidol.
Salmeterol
Salmeterol may increase the QTc-prolonging activities of Droperidol.
Saquinavir
Droperidol may increase the QTc-prolonging activities of Saquinavir.
Saquinavir Mesylate
Droperidol may increase the QTc-prolonging activities of Saquinavir.
Scopolamine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Scopolamine.
Scopolamine Hydrobromide
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Scopolamine.
Secobarbital
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Secobarbital.
Selegiline
The risk or severity of adverse effects can be increased when Selegiline is combined with Droperidol.
Sertindole
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Sertindole.
Sertraline
The risk or severity of adverse effects can be increased when Droperidol is combined with Sertraline.
Sevoflurane
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Sevoflurane.
Sodium Oxybate
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Solifenacin
Solifenacin may increase the QTc-prolonging activities of Droperidol.
Sorafenib
Sorafenib may increase the QTc-prolonging activities of Droperidol.
Sotalol
Droperidol may increase the QTc-prolonging activities of Sotalol.
Sufentanil
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Sufentanil.
Sulfamethoxazole
Sulfamethoxazole may increase the QTc-prolonging activities of Droperidol.
Sulfisoxazole
Sulfisoxazole may increase the QTc-prolonging activities of Droperidol.
Sulpiride
Droperidol may increase the antipsychotic activities of Sulpiride.
Sumatriptan
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Droperidol.
Sumatriptan Succinate
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Droperidol.
Sunitinib
Sunitinib may increase the QTc-prolonging activities of Droperidol.
Suvorexant
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tamoxifen
Tamoxifen may increase the QTc-prolonging activities of Droperidol.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Droperidol.
Tasimelteon
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tasimelteon.
Tedizolid
The risk or severity of adverse effects can be increased when Tedizolid Phosphate is combined with Droperidol.
Tedizolid Phosphate
The risk or severity of adverse effects can be increased when Tedizolid Phosphate is combined with Droperidol.
Telavancin
Droperidol may increase the QTc-prolonging activities of Telavancin.
Telithromycin
Droperidol may increase the QTc-prolonging activities of Telithromycin.
Temazepam
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Temazepam.
Terbutaline
Terbutaline may increase the QTc-prolonging activities of Droperidol.
Terbutaline Sulfate
Terbutaline may increase the QTc-prolonging activities of Droperidol.
Tetrabenazine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tetrabenazine.
Tetracaine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tetracaine.
Tetracaine hydrochloride
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Droperidol.
Thalidomide
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Thiamylal
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Thiamylal.
Thiopental
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Thiopental.
Thiopental Sodium
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Thiopental.
Thioridazine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Thioridazine.
Thiothixene
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.
Tiagabine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tiagabine.
Tiapride
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tiapride.
Tizanidine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tizanidine.
Tolcapone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tolcapone.
Tolterodine
Tolterodine may increase the QTc-prolonging activities of Droperidol.
Topiramate
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Topiramate.
Toremifene
Droperidol may increase the QTc-prolonging activities of Toremifene.
Tramadol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tramadol.
Tranylcypromine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tranylcypromine.
Trazodone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Trazodone.
Treprostinil
Treprostinil may increase the QTc-prolonging activities of Droperidol.
Triazolam
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Triazolam.
Triazulenone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Loprazolam.
Trifluoperazine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Trifluoperazine.
Triflupromazine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Triflupromazine.
Trimethoprim
Trimethoprim may increase the QTc-prolonging activities of Droperidol.
Trimipramine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Trimipramine.
Triprolidine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Triprolidine.
Triptorelin
Triptorelin may increase the QTc-prolonging activities of Droperidol.
Urethane
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ethyl carbamate.
Valproate
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Valproic Acid.
Valproic Acid
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Valproic Acid.
Vandetanib
Droperidol may increase the QTc-prolonging activities of Vandetanib.
Vardenafil
Vardenafil may increase the QTc-prolonging activities of Droperidol.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Droperidol.
Venlafaxine
The risk or severity of adverse effects can be increased when Droperidol is combined with Venlafaxine.
Vigabatrin
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Vigabatrin.
Vilanterol
Vilanterol may increase the QTc-prolonging activities of Droperidol.
Vilazodone
The risk or severity of adverse effects can be increased when Vilazodone is combined with Droperidol.
Voriconazole
Voriconazole may increase the QTc-prolonging activities of Droperidol.
Vorinostat
Vorinostat may increase the QTc-prolonging activities of Droperidol.
Vortioxetine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.
Zaleplon
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Zaleplon.
Ziconotide
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ziconotide.
Ziprasidone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ziprasidone.
Zolmitriptan
The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Droperidol.
Zolpidem
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Zonisamide.
Zopiclone
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.
Zotepine
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Zotepine.
Zuclopenthixol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Zuclopenthixol.
